The study team reviewed records from 87,087 adult admissions to two Italian university hospitals between 2016 and 2019. They excluded patients with stage 5 chronic kidney disease and defined acute kidney injury using Kidney Disease: Improving Global Outcomes creatinine-based criteria applied to in-hospital serum creatinine trends. AKI occurred in 20.6% of the cohort; the investigators reported a higher crude incidence in females (21.4%) than in males (19.8%). These headline rates frame the subsequent, more detailed comparisons across age strata and disease severity.
Females in the cohort were older at admission and presented with lower estimated glomerular filtration rate (eGFR) on arrival, according to the authors. They also had a lower recorded prevalence of diabetes and of chronic kidney disease, but a higher frequency of congestive heart failure diagnoses. These divergent comorbidity patterns coexist with the age difference and complicate simple sex-based comparisons — the data indicated a complex interplay of baseline risk factors that the investigators explored further through stratified analyses.
Stage 3 AKI was more commonly observed in male patients, the authors noted. In contrast, females had a higher proportion of undiagnosed AKI when limited to stage 1 events, suggesting potential recognition or coding gaps that vary by sex. The paper did not provide granular descriptions of diagnostic workflows or specific reasons for under-recognition; the source did not report whether urine output criteria or additional biomarker data were used beyond serum creatinine trends. The team relied on administrative and laboratory data to classify AKI, which shapes interpretation of recognition patterns.
When investigators stratified the cohort by age quartiles, a dynamic pattern emerged. In younger age groups, males showed a higher incidence of AKI. That pattern reversed in the oldest age quartiles, where females demonstrated progressively higher AKI incidence. Despite this shift in incidence toward older females, in-hospital outcomes diverged: mortality, Intensive Care Unit admission, and length of hospital stay were worse among older male patients with AKI. The authors therefore described an age-dependent sex interaction that alters both incidence and outcome profiles across the adult lifespan.
This was a retrospective observational analysis of clinical and administrative hospital records. The investigators applied KDIGO creatinine-based thresholds to serial serum creatinine measurements during hospitalization to identify AKI events. Demographic variables, comorbidities, admission eGFR, length of stay, ICU admission, and in-hospital mortality comprised the main variables reported for sex-based comparisons. The source abstract did not present detailed statistical modeling parameters, adjustment covariates, or sensitivity analyses in the text provided; those elements may appear in the full article but were not described in the abstract.
The authors acknowledged that AKI incidence and outcomes differ by sex in an age-dependent manner, and they argued for inclusion of sex-by-age interaction in epidemiologic investigations. The retrospective design and reliance on administrative and laboratory records limit causal inference and raise the possibility of misclassification or undercapture of AKI events, particularly when recognition differed by stage and sex. The abstract did not report whether urine output data or novel biomarkers were incorporated, nor did it specify the extent to which coding practices or clinical recognition contributed to the observed sex differences. External validity is constrained by the two-hospital Italian sample; the source did not state whether the cohort is generalizable to other health systems or geographic regions. Finally, the paper leaves open specific mechanistic questions — for example, the biological versus health-system drivers of the sex-by-age interaction — that require prospective, ideally multicenter, study designs to resolve.